Carla Mamolo
Roche (United States)(US)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Health Systems, Economic Evaluations, Quality of Life
Most-Cited Works
- → Topical tofacitinib for atopic dermatitis: a phase II a randomized trial(2016)410 cited
- → Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial(2016)98 cited
- → Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes(2015)95 cited
- → Tofacitinib (CP‐690,550), an oral Janus kinase inhibitor, improves patient‐reported outcomes in a phase 2b, randomized, double‐blind, placebo‐controlled study in patients with moderate‐to‐severe psoriasis(2013)76 cited
- → Increased Cause-specific Mortality in Patients with Mild and Severe Psoriasis: A Population-based Swedish Register Study(2014)68 cited
- → Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis(2016)65 cited
- → Under-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan Data(2016)63 cited
- → <p>Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews</p>(2020)60 cited
- → The effects of skill demands and object position on the distribution of preferred hand reaches(2004)58 cited
- → Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States(2015)56 cited